254 related articles for article (PubMed ID: 9315348)
1. Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
Talom RT; McNeill JR
Can J Physiol Pharmacol; 1997 Jul; 75(7):812-7. PubMed ID: 9315348
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
3. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
Styś T; Szczepańska-Sadowska E
J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233
[TBL] [Abstract][Full Text] [Related]
4. Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
Tagami M; Ikeda K; Nara Y; Fujino H; Kubota A; Numano F; Yamori Y
Lab Invest; 1995 Feb; 72(2):174-82. PubMed ID: 7853851
[TBL] [Abstract][Full Text] [Related]
5. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen in the regulation of nitric oxide pathway during development of hypertension in rats.
Doursout MF; Chelly JE
Proc West Pharmacol Soc; 2002; 45():49-52. PubMed ID: 12434525
[TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
8. Sympathectomy exaggerates antihypertensive effect of vasopressin withdrawal.
Chiu EK; McNeill JR
Am J Physiol; 1995 Jan; 268(1 Pt 2):H1-6. PubMed ID: 7840254
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine.
Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
Brain Res; 1997 Feb; 748(1-2):51-61. PubMed ID: 9067444
[TBL] [Abstract][Full Text] [Related]
11. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
[TBL] [Abstract][Full Text] [Related]
12. Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats.
Jablonskis LT; Howe PR
J Hypertens; 1995 Mar; 13(3):319-25. PubMed ID: 7622853
[TBL] [Abstract][Full Text] [Related]
13. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
Liu YC; Kao SJ; Chuang IC; Chen HI
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
[TBL] [Abstract][Full Text] [Related]
15. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
Bugajski J; Gadek-Michalska A; Głód R; Borycz J
J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
[TBL] [Abstract][Full Text] [Related]
16. Role of sodium and water excretion in the antihypertensive effect of vasopressin in the spontaneously hypertensive rat.
Chiu EK; Wang H; McNeill JR
Can J Physiol Pharmacol; 1992 Oct; 70(10):1309-14. PubMed ID: 1490249
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
18. Role of autonomic function in the antihypertensive effect of vasopressin withdrawal in spontaneous hypertension.
Chiu EK; McNeill JR
Am J Hypertens; 1992 Mar; 5(3):187-92. PubMed ID: 1575946
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
20. Pressor responsiveness to vasopressin in spontaneously hypertensive rats.
Stepniakowski K; Lapiński M; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
Acta Physiol Pol; 1989; 40(2):171-82. PubMed ID: 2641416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
